Also, in a model of psoriasis caused by IMQ, using GLUT1 knockout mice or drug inhibitors, along with PKM2 inhibitors or glycolytic inhibitors such as 2-deoxy-D-glucose (2-DG), greatly decreased the development of psoriasis-like skin growths and lesions (99, 100). The gene discussed is SLC2A1; the disease is psoriasis.